MedTrace Logo

Compare Efficacy Nebulized and Intravenous Magnesium Sulphate in Thai Children

NCT02112305 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2014-11-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether nebulized magnesium sulphate is effective in the treatment of acute severe asthma when comparison with intravenous magnesium sulphate

Conditions

  • Acute Severe Asthma

Interventions

DRUG

isotonic magnesium sulphate

2.5 ml of isotonic magnesium sulphate (150 mg, 245 mmol/L) NB on three occasional at 20 minutes interval

DRUG

50% magnesium sulphate

magnesium sulphate 50mg/kg/dose intravenous drip in 20 minutes for one dose

Sponsors & Collaborators

  • Queen Sirikit National Institute of Child Health

    lead OTHER_GOV

Principal Investigators

  • Tassalapa Daengsuwan, Pediatrician · Queen Sirikit National Institute of Child Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02112305 on ClinicalTrials.gov